Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis - Scorecard - MDSpire
Advertisement
Pan-immune-inflammation value for risk stratification of adverse cardiovascular outcomes in acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Clinical Scorecard: Evaluating the Prognostic Significance of Pan-Immune-Inflammation Value in Assessing Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
PIV integrates neutrophil, platelet, monocyte, and lymphocyte counts.
Target Population
Care Setting
Key Highlights
Remove unsupported conclusions.
Guideline-Based Recommendations
Diagnosis
Attribution needed for the statement regarding PIV as a supplementary marker.
Management
Remove editorial interpretation.
Monitoring & Follow-up
Remove unsupported claims.
Risks
Attribution needed for the statement regarding elevated PIV.
Patient & Prescribing Data
Adults with acute coronary syndrome undergoing PCI
PIV may help identify patients at higher risk for adverse outcomes
Clinical Best Practices
Ensure practices are directly supported by the source.
